子社群 于重元 [19/19] 劉柯俊 [85/98] 劉滄梧 [119/125] 劉界元(2003-2010) [3/3] 夏和雄(1996-2012) [26/31] 夏興國 [51/54] 姜乃榕 [82/94] 常慧如 [39/44] 張俊彥 [234/254] 張光裕 [69/79] 張憶壽 [103/106] 張文祥 [52/53] 張書銘 [89/91] 彭汪嘉康(1996-2007) [120/126] 施能耀 [37/43] 李家惠 [29/29] 李岳倫 [48/49] 林素芳 [32/32] 楊奕馨 [41/42] 江士昇 [88/90] 沈哲宏 [14/16] 洪文俊 [88/88] 莊雙恩 [82/91] 蔡坤志 [32/34] 蔡慧珍 [66/71] 蘇勇曄 [40/40] 蘇振良 [24/25] 郭靜娟 [71/76] 陳尚鴻 [45/48] 陳振陽 [72/72] 陳立宗 [443/510] 陳美霞(2002-2009) [1/1] 陳詩政 [2/2] 陳雅雯 [38/39] 黃智興 [55/55] 黃道揚 [26/26] 丁兆治(2000-2004) [5/5] 其他 [464/471] 劉敏(1996-2007) [60/62] 劉玫英(2004-2006) [2/2] 吳成文(1996-2008) [53/55] 曾思文(1997-2007) [4/4] 李冠德(1997-2004) [4/6] 林景太(1999-2007) [5/5] 楊文光(1996-1999) [21/21] 王全正(1996-2003) [4/4] 莊聲宏(1997-2004) [11/11] 詹宗晃(2000-2008) [2/2] 賴基銘(2004-2008) [41/47] 阮麗蓉(2000-2006) [6/7] 陳俊叡(2003-2007) [6/6] 馬彥英(1997-1999) [1/1] 黃奇英(2005-2007) [9/10] 邻近社群 分子與基因醫學研究所 [921/964] 生技與藥物研究所 [830/1008] 生醫工程與奈米醫學研究所 [1214/1334] 免疫醫學研究中心 [224/236] 神經及精神醫學研究中心 [782/804] 細胞及系統醫學研究所 [755/815] 感染症與疫苗研究所 [1541/1618] 群體健康科學研究所 [2870/3000] 國家環境醫學研究所 [1560/1591] 國家蚊媒傳染病防治研究中心 [102/104] 高齡醫學暨健康福祉研究中心 [216/224] 論壇 [2/2] 生醫資源中心 [7/7] 研究生培育合作學程 [188/191] 核心儀器設施中心 [9/9] 病理核心實驗室 [14/14] 實驗動物中心 [8/8] 行政管理部門 [18/18] 社群统计 近3年内发表的文件:335(13.91%) 含全文笔数:2250(93.40%) 文件下载次数统计 下载大于0次:2250(100.00%) 下载大于100次:2250(100.00%) 全文下载总次数:1608490(30.01%) 最后更新时间: 2024-11-28 15:40 上传排行 数据加载中..... 下载排行 数据加载中..... 最近上传 Pathological response following neo... Registry of genetic alterations of ... Activated single nucleotide mismatc... Taiwan nationwide study of first-li... The effectiveness of virtual passpo... Special Issue "Bioinformatics ... Evaluating a natural language proce... The clinicopathological significanc... Hypoxia in drug resistance and radi... DKK1 as a chemoresistant protein mo...

跳至: (选择年份) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (选择月份) January February March April May June July August September October November December 或输入年份:

由新到旧排序 由最旧的开始

显示项目2176-2200 / 2409. (共97页) << < 83 84 85 86 87 88 89 90 91 92 > >> 每页显示[10|25|50]项目

日期	题名	關聯
2004-07-15	A novel bis-benzylidenecyclopentanone derivative, BPR0Y007, inducing a rapid caspase activation involving upregulation of Fas (CD95/APO-1) and wild-type p53 in human oral epidermoid carcinoma cells	Biochemical Pharmacology. 2004 Jul;68(2):293-303.
2004-07-10	Promoter polymorphisms of tumor necrosis factor-alpha are associated with risk of gastric mucosa-associated lymphoid tissue lymphoma	International Journal of Cancer. 2004 Jul;110(5):695-700.
2004-07-01	BPR0L075, a novel synthetic indole compound with antimitotic activity in human cancer cells, exerts effective antitumoral activity in vivo	Cancer Research. 2004 Jul;64(13):4621-4628.
2004-07-01	Interleukin-6 is responsible for drug resistance and anti-apoptotic effects in prostatic cancer cells	Prostate. 2004 Jul;60(2):120-129.
2004-07	Impact of severe acute respiratory syndrome on the status of lung cancer chemotherapy patients and a correlation of the signs and symptoms	Lung Cancer. 2004 Jul;45(1):39-43.
2004-07	Cock spermatozoa serve as the gene vector for generation of transgenic chicken (Gallus gallus)	Asian-Australasian Journal of Animal Sciences. 2004 Jul;17(7):885-891.
2004-07	Recent advances in non-surgical treatment for advanced hepatocellular carcinoma	Journal of the Formosan Medical Association. 2004 Jul;103(7):483-495.
2004-07	Comparison of the antitumor activity of thalidomide between hepatitis B (HBV)and hepatitis C (HCV)-related hepatocellular carcinoma (HCC)	Journal of Clinical Oncology. 2004 Jul;22(14):Abstract number 362S.
2004-07	Preliminary report of a randomized trial of different docetaxel schedules in non-small cell lung cancer patients failing previous chemotherapy	Journal of Clinical Oncology. 2004 Jul;22(14):Abstract number 644.
2004-07	Drug design for BPR0L075 as an anticancer agent	Medicine in the 21st Century Tri-Conference & Bio-Forum 2004 Shanghai International Convention Center. 2004 Jul.
2004-06-18	Suppression of MEK/ERK signaling pathway enhances cisplatin-induced NF-kappa B activation by protein phosphatase 4-mediated NF-kappa B p65 Thr dephosphorylation	Journal of Biological Chemistry. 2004 Jun;279(25):26143-26148.
2004-06-07	Thermoinactivaion analysis of vacuolar H+-pyrophosphatase	Biochimica Et Biophysica Acta-Bioenergetics. 2004 Jun;1656(2-3):88-95.
2004-06-04	Cyr61 expression confers resistance to apoptosis in breast cancer MCF-7 cells by a mechanism of NF-kappa B-dependent XIAP up-regulation	Journal of Biological Chemistry. 2004 Jun;279(23):24015-24023.
2004-06-02	HCMV IE2-mediated inhibition of HAT activity downregulates p53 function	EMBO Journal. 2004 Jun;23(11):2269-2280.
2004-06	Complete remission of metastatic pancreatic cancer with cardiac involvement after gemcitabine, oxaliplatin and 46-h infusion of 5-fluorouracil/leucovorin	Journal of Gastroenterology and Hepatology. 2004 Jun;19(6):716-717.
2004-06	Acute hemorrhagic rectal ulcer syndrome: A new clinical entity? Report of 19 cases and review of the literature	Diseases of the Colon and Rectum. 2004 Jun;47(6):895-903.
2004-06	Impact of circulating free tumor cells in the peripheral blood of colorectal cancer patients during laparoscopic surgery	World Journal of Surgery. 2004 Jun;28(6):552-557.
2004-05-20	Synthesis and structure-activity relationships of 3-aminobenzophenones as antimitotic agents	Journal of Medicinal Chemistry. 2004 May;47(11):2897-2905.
2004-05-04	Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/leucovorin for locally advanced or metastatic carcinoma of the biliary tract	British Journal of Cancer. 2004 May;90(9):1715-1719.
2004-05-01	Identification and characterization of the conserved nucleoside-binding sites in the Epstein-Barr virus thymidine kinase	Biochemical Journal. 2004 May;379(Pt. 3):795-803.
2004-05	Platelet aggregation induced by serotype polysaccharides from Streptococcus mutans	Infection and Immunity. 2004 May;72(5):2605-2617.
2004-04-29	Phosphorylation of p53 on Thr55 by ERK2 is necessary for doxorubicin-induced p53 activation and cell death	Oncogene. 2004 Apr;23(20):3580-3588.
2004-04-23	YY1AP, a novel co-activator of YY1	Journal of Biological Chemistry. 2004 Apr;279(17):17750-17755.
2004-04-15	Association between vitamin D receptor polymorphisms and prostate cancer risk in a Taiwanese population	Cancer Letters. 2004 Apr;207(1):69-77.
2004-04-15	Generation of carcinoembryonic antigen (CEA)-specific T-cell responses in HLA-A*0201 and HLA-A*2402 late-stage colorectal cancer patients after vaccination with dendritic cells loaded with CEA peptides	Clinical Cancer Research. 2004 Apr;10(8):2645-2651.

显示项目2176-2200 / 2409. (共97页) << < 83 84 85 86 87 88 89 90 91 92 > >> 每页显示[10|25|50]项目